Xencor, Inc. (XNCR)
11.44
+0.17
(+1.51%)
USD |
NASDAQ |
May 22, 10:02
Xencor EPS Diluted (Quarterly) : -1.713 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Rigel Pharmaceuticals, Inc. | 0.4396 |
| Ultragenyx Pharmaceutical, Inc. | -1.839 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -128.92M |
| Revenue (Quarterly) | 4.516M |
| Total Expenses (Quarterly) | 133.43M |
| Enterprise Value | 565.79M |
| Gross Profit Margin (Quarterly) | 43.16% |
| Profit Margin (Quarterly) | -2.85K% |
| Earnings Yield | -20.09% |
| Normalized Earnings Yield | -23.00 |